| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 |
| filingDate |
1996-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d78ab4527fdea33cd9e19f2b7fc5c192 |
| publicationDate |
2000-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6051218-A |
| titleOfInvention |
Tumor radiosensitization using gene therapy |
| abstract |
The invention provides a method of radiosensitizing a tumor in a subject by contacting the tumor with a cytokine or a nucleic acid molecule encoding a cytokine. The invention also provides a method of radiosensitizing a tumor in a subject by administering, at a site other than the tumor, a cell genetically modified to express a cytokine. The invention further provides a method of reducing the severity of a cancer in a subject by administering a cytokine at the site of the tumor or by immunizing the subject at a site other than the tumor with tumor cells genetically modified to express a cytokine, and treating the tumor with radiotherapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20030688-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02070494-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6403370-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-014954-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008057029-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7247297-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7264820-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005245525-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7608618-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6277368-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005169897-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7364726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010105683-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003091539-A1 |
| priorityDate |
1996-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |